Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia

Introduction: Reverse transcriptase-polymerase chain reaction (RT-PCR) assay is a useful tool for the detection of fusion transcript resulting from specific chromosomal translocation of the leukemia cells. A specific chromosomal abnormality, the Philadelphia chromosome (Ph), is present in 90% to 95%...

Full description

Bibliographic Details
Main Authors: Yaghmaie M., Ghaffari S.H., Alimoghaddam K., Ghavamzadeh A., Mousavi S.A., Irvani M., Bahar B., Bibordi E., Jahani M
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-09-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/3197.pdf&manuscript_id=3197
_version_ 1797719253996011520
author Yaghmaie M.
Ghaffari S.H.
Alimoghaddam K.
Ghavamzadeh A.
Mousavi S.A.
Irvani M.
Bahar B.
Bibordi E.
Jahani M
author_facet Yaghmaie M.
Ghaffari S.H.
Alimoghaddam K.
Ghavamzadeh A.
Mousavi S.A.
Irvani M.
Bahar B.
Bibordi E.
Jahani M
author_sort Yaghmaie M.
collection DOAJ
description Introduction: Reverse transcriptase-polymerase chain reaction (RT-PCR) assay is a useful tool for the detection of fusion transcript resulting from specific chromosomal translocation of the leukemia cells. A specific chromosomal abnormality, the Philadelphia chromosome (Ph), is present in 90% to 95% of CML patients.The aberration results from a reciprocal translocation between chromosome 9 and 22, creating a BCR-ABL fusion gene.There are two major forms of the BCR/ABL fusion gene, involving ABL exon 2, but including different exons of BCR gene. The transcripts b2a2 or b3a2 code for a p210 protein. Another fusion gene leads to the expression of an e1a2 transcript, which codes for a p190 pro-tein. Another, less common fusion genes are b3a3 or b2a3 (p203) and e19a2 (p230). The incidence of one or other rearrangement in chronic myeloid leukemia (CML) patients varies in different reported se-ries. In general, fusion transcripts are determined individually, a process which is labor intensive in or-der to detect all major fusion transcripts. Methods: This study was designed to determine the frequency of different fusion genes in 75 iranian patients with CML. peripheral blood samples were analyzed by multiplex reverse transcriptase poly-merase chain reaction (RT-PCR) from adult patients to detect all types of BCR-ABL transcripts of the t (9:22) and found that all cases were positive for some type of BCR/ABL rearrangement. Results: Most of our patients showed b3a2 fusion gene (62%), while the remaining showed one of the transcripts of b2a2, b3a3, b2a3, e1a2 or coexpression of b3a2 and b2a2. The rate of coexpression of the b3a2 and b2a2 was 5%. Conclusion: In contrast to the other reports, we did not see any coexpression of p210/p190. This may reflect either the sensitivity of the detection techniques used or the possibility of genetic differences be-tween the populations studied. Coexpression may be due to alternative splicing or to phenotypic varia-tion, with clinical course different from classical CML.
first_indexed 2024-03-12T09:02:10Z
format Article
id doaj.art-d8cdad1e2afb4f0f92f0de449cadcbae
institution Directory Open Access Journal
issn 2008-3009
2008-2207
language English
last_indexed 2024-03-12T09:02:10Z
publishDate 2005-09-01
publisher Tehran University of Medical Sciences
record_format Article
series International Journal of Hematology-Oncology and Stem Cell Research
spelling doaj.art-d8cdad1e2afb4f0f92f0de449cadcbae2023-09-02T15:37:08ZengTehran University of Medical SciencesInternational Journal of Hematology-Oncology and Stem Cell Research2008-30092008-22072005-09-012315Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid LeukemiaYaghmaie M.Ghaffari S.H.Alimoghaddam K.Ghavamzadeh A.Mousavi S.A.Irvani M.Bahar B.Bibordi E.Jahani MIntroduction: Reverse transcriptase-polymerase chain reaction (RT-PCR) assay is a useful tool for the detection of fusion transcript resulting from specific chromosomal translocation of the leukemia cells. A specific chromosomal abnormality, the Philadelphia chromosome (Ph), is present in 90% to 95% of CML patients.The aberration results from a reciprocal translocation between chromosome 9 and 22, creating a BCR-ABL fusion gene.There are two major forms of the BCR/ABL fusion gene, involving ABL exon 2, but including different exons of BCR gene. The transcripts b2a2 or b3a2 code for a p210 protein. Another fusion gene leads to the expression of an e1a2 transcript, which codes for a p190 pro-tein. Another, less common fusion genes are b3a3 or b2a3 (p203) and e19a2 (p230). The incidence of one or other rearrangement in chronic myeloid leukemia (CML) patients varies in different reported se-ries. In general, fusion transcripts are determined individually, a process which is labor intensive in or-der to detect all major fusion transcripts. Methods: This study was designed to determine the frequency of different fusion genes in 75 iranian patients with CML. peripheral blood samples were analyzed by multiplex reverse transcriptase poly-merase chain reaction (RT-PCR) from adult patients to detect all types of BCR-ABL transcripts of the t (9:22) and found that all cases were positive for some type of BCR/ABL rearrangement. Results: Most of our patients showed b3a2 fusion gene (62%), while the remaining showed one of the transcripts of b2a2, b3a3, b2a3, e1a2 or coexpression of b3a2 and b2a2. The rate of coexpression of the b3a2 and b2a2 was 5%. Conclusion: In contrast to the other reports, we did not see any coexpression of p210/p190. This may reflect either the sensitivity of the detection techniques used or the possibility of genetic differences be-tween the populations studied. Coexpression may be due to alternative splicing or to phenotypic varia-tion, with clinical course different from classical CML.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/3197.pdf&manuscript_id=3197 BCR-ABLCMLMultiplex RT-PC
spellingShingle Yaghmaie M.
Ghaffari S.H.
Alimoghaddam K.
Ghavamzadeh A.
Mousavi S.A.
Irvani M.
Bahar B.
Bibordi E.
Jahani M
Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
International Journal of Hematology-Oncology and Stem Cell Research
BCR-ABL
CML
Multiplex RT-PC
title Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
title_full Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
title_fullStr Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
title_full_unstemmed Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
title_short Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
title_sort frequency of bcr abl fusion transcript in iranian patients with chronic myeloid leukemia
topic BCR-ABL
CML
Multiplex RT-PC
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/3197.pdf&manuscript_id=3197
work_keys_str_mv AT yaghmaiem frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT ghaffarish frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT alimoghaddamk frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT ghavamzadeha frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT mousavisa frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT irvanim frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT baharb frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT bibordie frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia
AT jahanim frequencyofbcrablfusiontranscriptiniranianpatientswithchronicmyeloidleukemia